The rise of GLP-1 medications is not just transforming how much Americans eat, it’s reshaping what they choose to eat. New data from CookUnity, the chef-led meal delivery platform connecting eaters ...

Oral weight-loss medications could widen demand, but the bigger issue is whether coverage is becoming a must-have benefit or ...

A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight ...

Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market. And in recent years, their popularity has soared due to ...

The U.S. Food and Drug Administration (FDA) recently approved Eli Lilly and Company’s oral GLP-1 receptor agonist, Foundayo (orforglipron), ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among patients of different ages, races, and starting weights, with women benefiting ...

Insurance coverage for GLP-1 medications is more likely for type 2 diabetes than for weight loss. Coverage for weight loss depends on your specific insurance plan, as some employers exclude it.

Recent research and clinical updates highlight how GLP-1 receptor agonists are transforming diabetes and obesity care, with expanding uses from adolescents with type 2 diabetes to off-label ...

ColonBroom is taking a more targeted approach. The company has launched an upgraded version of its GLP-1 Premium formula, ...